Analysis of drug-induced interstitial lung disease using the Japanese Adverse Drug Event Report database

SAGE Open Medicine
Kiyoka MatsumotoMitsuhiro Nakamura

Abstract

Drug-induced interstitial lung disease occurs when exposure to a drug causes inflammation and, eventually, fibrosis of the lung interstitium. Drug-induced interstitial lung disease is associated with substantial morbidity and mortality. The aim of this retrospective study was to obtain new information on the time-to-onset profiles of drug-induced interstitial lung disease by consideration of other associated clinical factors using the Japanese Adverse Drug Event Report database. We identified and analyzed reports of drug-induced interstitial lung disease between 2004 and 2018 from the Japanese Adverse Drug Event Report database. The reporting odds ratio and 95% confidence interval was used to detect the signal for each drug-induced interstitial lung disease incidence. We evaluated the time-to-onset profile of drug-induced interstitial lung disease and used the applied association rule mining technique to uncover undetected relationships, such as possible risk factors. The reporting odds ratios (95% confidence intervals) of drug-induced interstitial lung disease due to temsirolimus, gefitinib, sho-saiko-to, sai-rei-to, osimertinib, amiodarone, alectinib, erlotinib, everolimus, and bicalutamide were 18.3 (15.6-21.3), 17.8 (16.5-1...Continue Reading

References

Sep 1, 1989·The Annals of Thoracic Surgery·J P KupferschmidR E Clark
Oct 1, 1994·American Journal of Respiratory and Critical Care Medicine·D B CoultasR E Sobonya
Mar 8, 2000·The European Respiratory Journal·S ImokawaR A Helmers
May 10, 2002·Pharmacoepidemiology and Drug Safety·Eugène P van PuijenbroekAntoine C G Egberts
Jun 20, 2002·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Ana SzarfmanRobert T O'Neill
Dec 19, 2002·Annals of Oncology : Official Journal of the European Society for Medical Oncology·J M O'SullivanA Horwich
Apr 13, 2006·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Marta HamiltonPablo J Cagnoni
Sep 27, 2007·Circulation Journal : Official Journal of the Japanese Circulation Society·Yuichiro YamadaHiroshi Kasanuki
Mar 14, 2008·American Journal of Respiratory and Critical Care Medicine·Shoji KudohFredrik Nyberg
Nov 26, 2008·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Petal A H M WijnenOtto Bekers
Mar 27, 2009·Rheumatology·Batsi ChikuraJulie K Dawson
Sep 4, 2009·Journal of Human Hypertension·M P C KaoA D Struthers
Jul 2, 2010·Current Opinion in Pulmonary Medicine·Petal A H M WijnenMarjolein Drent
Feb 14, 2012·Japanese Journal of Clinical Oncology·Megumi IshiguroKenichi Sugihara
Aug 17, 2012·The Open Respiratory Medicine Journal·Martin SchwaiblmairThomas Berghaus
Dec 22, 2012·Internal Medicine·Kosaku KomiyaJun-ichi Kadota
May 16, 2013·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Odile SauzetVictoria R Cornelius
Mar 5, 2014·European Respiratory Review : an Official Journal of the European Respiratory Society·Katerina M AntoniouVenerino Poletti
Jun 14, 2014·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Meaghan O'MalleyNithya Ramnath
Jul 23, 2015·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Perrine CréquitJacques Cadranel
Jan 15, 2016·Applied Clinical Informatics·P Yildirim
Dec 5, 2017·Biological & Pharmaceutical Bulletin·Satoshi NakaoMitsuhiro Nakamura
Feb 2, 2018·Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan·Fusao Komada
Apr 11, 2018·Seminars in Diagnostic Pathology·Anja C Roden, Philippe Camus
Oct 18, 2018·Journal of Clinical Medicine·Sarah SkeochNazia Chaudhuri
Dec 24, 2018·Journal of Pharmaceutical Health Care and Sciences·Haruna HatahiraMitsuhiro Nakamura

❮ Previous
Next ❯

Software Mentioned

FileMaker Pro
arulesViz
JMP
DIILD
arules
R

Related Concepts

Related Feeds

Antiarrhythmic Agents: Mechanisms of Action

Understanding the mechanism of action of antiarrhythmic agents is essential in developing new medications as treatment of cardiac arrhythmias is currently limited by the reduced availability of safe and effective drugs. Discover the latest research on Antiarrhythmic Agents: Mechanism of Action here.